Cargando…
Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei
The anticancer drug cisplatin executes its cytotoxic activity via formation of intra- and interstrand crosslinks in DNA. The relative contribution of structurally defined cisplatin adducts to induce apoptosis and the cellular processing of these lesions is still poorly understood mostly due to the l...
Autores principales: | Liedert, Bernd, Pluim, Dick, Schellens, Jan, Thomale, Jürgen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420801/ https://www.ncbi.nlm.nih.gov/pubmed/16571898 http://dx.doi.org/10.1093/nar/gkl051 |
Ejemplares similares
-
Quantitative detection of 4-hydroxyequilenin–DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody
por: Okahashi, Yumiko, et al.
Publicado: (2010) -
Sequence-specific microscopic visualization of DNA methylation status at satellite repeats in individual cell nuclei and chromosomes
por: Li, Yufeng, et al.
Publicado: (2013) -
Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008) -
Ultrasensitive isolation, identification and quantification of DNA–protein adducts by ELISA-based RADAR assay
por: Kiianitsa, Kostantin, et al.
Publicado: (2014) -
Sensitive CometChip assay for screening potentially carcinogenic DNA adducts by trapping DNA repair intermediates
por: Ngo, Le P, et al.
Publicado: (2020)